Cargando…

The role of heparin in reducing in-hospital complications and three-month mortality rates in hospitalized COVID-19 patients

Detalles Bibliográficos
Autores principales:	Calabretta, F., Preti, P.S., Russo, M., Klersy, C., Di Sabatino, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923898/ https://www.ncbi.nlm.nih.gov/pubmed/35307245 http://dx.doi.org/10.1016/j.ejim.2022.03.015

Ejemplares similares

Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
por: Preti, Paola S., et al.
Publicado: (2021)

Decreased mortality among hospitalized coronavirus disease 2019 patients who underwent anticoagulant therapy with heparin
por: Yethindra, Vityala, et al.
Publicado: (2020)

Might hydrogen peroxide reduce the hospitalization rate and complications of SARS-CoV-2 infection?
por: Caruso, Arturo A., et al.
Publicado: (2020)

Casirivimab-imdevimab treatment is associated with reduced rates of mortality and hospitalization in patients with COVID-19: A systematic review with meta-analysis
por: Gao, Ming, et al.
Publicado: (2023)

Incidence and mortality rates of acute ischemic stroke in hospitalized patients in the United States
por: Ramphul, Kamleshun, et al.
Publicado: (2021)

Determinants of COVID-19-related mortality in an internal medicine setting
por: Lenti, Marco Vincenzo, et al.
Publicado: (2022)

Reply to “In-Hospital Mortality Risk of Older Patients With COVID-19 Infection”
por: Covino, Marcello, et al.
Publicado: (2022)

Temporal variation, socioeconomic status, and out‐of‐hospital deaths as factors that influence mortality rates among hospitalized COVID‐19 patients receiving ACEIs/ARBs
por: Aftab, Owais M., et al.
Publicado: (2022)

Bamlanivimab improves hospitalization and mortality rates in patients with COVID-19: A systematic review and meta-analysis
por: Zuo, Ling, et al.
Publicado: (2022)

Cardiovascular complications and predictors of mortality in hospitalized patients with COVID-19: a cross-sectional study from the Indian subcontinent
por: Lalani, Kanhai, et al.
Publicado: (2022)

Reduced mortality rate after coronavac vaccine among healthcare workers
por: Akpolat, Tekin, et al.
Publicado: (2021)

Can heparin therapy reduce 28-day mortality in adult severe sepsis patients?
por: Jiang, Li-bing, et al.
Publicado: (2015)

Post-COVID-19 functional status six-months after hospitalization
por: Taboada, Manuel, et al.
Publicado: (2021)

Predictors of in-hospital mortality in patients with acute myocardial infarction complicated by cardiogenic shock in the contemporary era of primary percutaneous coronary intervention
por: Ho, Hee Hwa, et al.
Publicado: (2014)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Allione, Attilio, et al.
Publicado: (2020)

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients: comment
por: Roncon, Loris, et al.
Publicado: (2020)

In-hospital Mortality Rates in SARS-CoV-2 Patients Treated with Enoxaparin and Heparin
por: Alroomi, Moudhi, et al.
Publicado: (2022)

The Rating of Voluntary Hospitals
por: Wardell, Mary
Publicado: (1897)

Nebulized Heparin to Reduce COVID-19-induced Acute Lung Injury: A Prospective Observational Study
por: Gupta, Bhavna, et al.
Publicado: (2023)

Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital
por: Arcari, Gabriele, et al.
Publicado: (2021)

Heparin induced thrombocytopenia-type 2
por: Majeed, Tanveer A.
Publicado: (2010)

Refractory hyperkalemia related to heparin abuse
por: Bawaskar, Himmatrao S., et al.
Publicado: (2014)

Heparin-induced bullous hemorrhagic dermatosis()
por: Hamdi, Douja, et al.
Publicado: (2022)

Multiple in-hospital counseling increases six-month smoking abstinence among individuals participating in a hospital-initiated smoking cessation program
por: Kuo, Chin-Wei, et al.
Publicado: (2022)

Tapping into the Resources of Skilled Birth Attendants in Reducing the Maternal Mortality Rates in Developing Nations
por: Shrivastava, Saurabh R., et al.
Publicado: (2017)

The Recovery Rate in Mental Hospitals
por: Urquhart, A. R.
Publicado: (1912)

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
por: Pawlowski, Colin, et al.
Publicado: (2021)

In-Hospital Mortality Risk of Older Patients With COVID-19 Infection
por: Kawada, Tomoyuki
Publicado: (2022)

Re: Heparin-induced thrombocytopenia – Type 2
por: Yagnik, Vipul D.
Publicado: (2011)

Hepatitis E Virus and Porcine-derived Heparin
por: Crossan, C., et al.
Publicado: (2013)

Type and dose of heparin in Covid‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020)

COVID-19-related symptom clustering in a primary care vs internal medicine setting
por: Lenti, Marco Vincenzo, et al.
Publicado: (2021)

Three months of loneliness during the COVID-19 lockdown
por: Killgore, William D.S., et al.
Publicado: (2020)

Arterial thrombotic complications in hospitalized patients with COVID-19. Response to related letters
por: Rey, Juan R., et al.
Publicado: (2021)

Hospital beds wireless sensor network and reducing decubitus ulcer
por: Ajami, Sima, et al.
Publicado: (2015)

Pattern of Maternal Mortality in a Tertiary Care Hospital of Patna, Bihar
por: Singh, Rashmi, et al.
Publicado: (2009)

Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico
por: Zhu, Feiyan, et al.
Publicado: (2021)

Don’t blame the nails for SARS-CoV-2 hospitalizations and mortality
por: Desai, Amar D., et al.
Publicado: (2022)

Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality
por: Speeckaert, Marijn M., et al.
Publicado: (2022)

Hypertriglyceridemia-induced acute pancreatitis treatment with insutin and heparin
por: Patel, Aalok D.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6icgbjmilkt6b0e14add4908e2